ARS-Patent writes about new domestic regulations intended to fight evergreening of pharmaceutical patents

Anna Pustogvar, patent expert at ARS-Patent, and Kirill Osipov, the Head of Legal Department of ARS-Patent, have been published in spring Newsletters of the AIPLA Chemical Practice Committee. They write about new domestic regulations intended to prevent evergreening of pharmaceutical patents.

Read the publication here (the PDF version is provided by AIPLA Chemical Practice Committee)

Make an enquiry